Martine G Caroff

Title: Martine G Caroff: Innovator in Antigenic Polysaccharides

Introduction

Martine G Caroff is a distinguished inventor based in Meudon de la Foret, France. She has made significant contributions to the field of immunology through her innovative research and development of antigenic polysaccharides. Her work has implications for the diagnosis and treatment of bacterial infections.

Latest Patents

Martine G Caroff holds a patent for an antigenic polysaccharide specific to Brucella abortus and Yersinia. The patent describes the antigenic O-chain polysaccharides from Brucella abortus and Yersinia enterocolitica serotype 0:9, which share a similar structure consisting of 1-2 linked 4,6-dideoxy-4-formamido-.alpha.-D-mannopyranosyl units. The antigen can be isolated more readily from Yersinia and can be chemically modified to include a hydrophobic moiety. This antigen can be adsorbed or coupled to carriers suitable for immunoassay applications, such as ELISA and RIA. Additionally, a monoclonal antibody capable of specifically binding to B. abortus and Y. enterocolitica has been produced, with assay procedures and kits described in her patent.

Career Highlights

Martine G Caroff is associated with Canadian Patents & Development Ltd., where she continues to advance her research in the field of immunology. Her innovative work has led to the development of important diagnostic tools that can aid in the detection of bacterial pathogens.

Collaborations

Throughout her career, Martine has collaborated with notable colleagues, including David R Bundle and Malcolm B Perry. These collaborations have enriched her research and contributed to the advancement of her patented technologies.

Conclusion

Martine G Caroff is a prominent inventor whose work on antigenic polysaccharides has the potential to significantly impact the field of immunology. Her contributions are vital for the development of diagnostic tools that can enhance public health.